AAD 2019: Anti-Interleukin Agents Show Greatest Efficacy in Meta-Analyses of Treatments for Plaque Psoriasis
Risankizumab emerges as the most effective in analyses sponsored by the drug’s manufacturer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.